[Oral administration of combined toluidine blue, hesperidin methylchalcone and vitamin C in therapy of hemorrhagic diseases].
D000284:Administration, Oral; D000814:Aniline Compounds / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D047188:Chalcones; D004396:Coloring Agents / Q000627:therapeutic use*; D005419:Flavonoids / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006569:Hesperidin / Q000031:analogs & derivatives; D007020:Hypoprothrombinemias; D007938:Leukemia / Q000628:therapy*; D011516:Prothrombin; D011693:Purpura; D011696:Purpura, Thrombocytopenic / Q000628:therapy*; D014048:Tolonium Chloride; D014815:Vitamins
D000814:Aniline Compounds; D047188:Chalcones; D004396:Coloring Agents; D005419:Flavonoids; D014815:Vitamins; D014048:Tolonium Chloride; C033022:hesperidin methylchalcone; D011516:Prothrombin; D006569:Hesperidin; D001205:Ascorbic Acid; C023650:aniline
ANILINE DYES/therapeutic use; HEMOPHILIA/therapy; LEUKEMIA/therapy; PROTHROMBIN/deficiency; PURPURA, THROMBOPENIC/therapy; VITAMIN C/therapeutic use; VITAMIN P/therapeutic use
L'associazione blu di toluidina-esperidina metilcalcone-vitamina c per os nella terapia delle malattie emorragiche.